Table 3.

Demographic and laboratory data in nasal polyp patient and control groups.

Nasal polyp group (n=46) (Patient No.)	Age	Gender	25(OH)D	VDR gene expression value	Control group (n=40) (Case No.)	Age	Gender	25(OH)D	VDR gene expression value
1	42	M	4.55	0	1	19	F	7.39	IS
2	48	M	7.75	IS	2	18	M	19.12	0
3	28	M	4.90	0	3	18	M	11.70	0
4	51	M	6.10	0	4	47	M	9.76	0
5	18	F	4.77	3.30	5	35	M	8.44	0
6	39	M	6.88	0	6	22	F	3.38	IS
7	37	M	7.25	0	7	18	M	4.07	0
8	25	M	8.77	0	8	37	M	12.08	0
9	26	M	11.14	0	9	46	M	12.14	0
10	27	M	11.25	0	10	18	M	25.18	0
11	47	M	11.55	0	11	25	M	6.64	0
12	56	M	17.46	9.20	12	40	F	6.32	IS
13	40	M	11.87	0	13	61	M	10.52	0
14	35	M	12.76	0.80	14	52	M	26.55	0
15	18	M	13.01	0	15	49	M	23.01	0
16	29	F	3.00	0	16	52	M	7.61	0
17	39	M	17.65	0	17	22	M	20.16	0
18	35	M	13.87	IS	18	20	F	7.95	0
19	34	M	20.02	0	19	24	M	6.16	IS
20	48	M	23.41	0	20	31	F	4.37	0
21	22	M	70.00	0	21	37	F	3.97	0
22	21	M	12.25	2.42	22	27	M	16.75	IS
23	64	F	3.00	0	23	64	F	23.22	0
24	33	F	4.11	0	24	41	M	17.88	IS
25	18	F	5.13	0	25	54	F	8.85	0
26	29	M	7.63	2.90	26	37	M	9.08	IS
27	19	F	6.18	0	27	41	F	3.37	0
28	33	M	7.47	IS	28	34	F	13.56	0
29	18	F	6.89	0	29	32	F	8.26	0
30	18	F	6.90	0	30	22	M	3.00	0.2
31	48	M	10.01	6.70	31	33	F	6.15	IS
32	32	F	70.00	0	32	26	M	6.26	IS
33	34	K	35.00	0	33	51	F	4.64	0
34	34	M	12.70	0	34	24	F	8.02	0
35	56	F	8.89	IS	35	21	F	10.66	0
36	25	F	5.25	0	36	53	M	8.40	IS
37	50	M	6.46	0	37	20	M	4.20	0
38	42	F	7.71	0	38	60	M	15.46	0
39	34	M	8.50	7.60	39	52	M	13.52	0
40	35	M	11.67	0	40	46	F	5.20	0
41	24	F	6.84	0
42	48	M	35.00	IS
43	22	M	19.87	0
44	36	M	4.81	0
45	27	F	8.25	IS
46	34	M	17.35	0

IS – insufficient sample; M – Male; F – Female; 25(OH)D – 25 (OH)Vitamin D; VDR – Vitamin D Receptor.